
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Triplepoint Venture Growth BDC Corp (TPVG)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: TPVG (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -53.88% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 280.96M USD | Price to earnings Ratio 8.54 | 1Y Target Price 7.62 |
Price to earnings Ratio 8.54 | 1Y Target Price 7.62 | ||
Volume (30-day avg) 315674 | Beta 1.93 | 52 Weeks Range 5.95 - 8.26 | Updated Date 04/2/2025 |
52 Weeks Range 5.95 - 8.26 | Updated Date 04/2/2025 | ||
Dividends yield (FY) 17.14% | Basic EPS (TTM) 0.82 |
Earnings Date
Report Date 2025-03-04 | When After Market | Estimate 0.3508 | Actual 0.32 |
Profitability
Profit Margin 29.62% | Operating Margin (TTM) 78.52% |
Management Effectiveness
Return on Assets (TTM) 6.1% | Return on Equity (TTM) 9.26% |
Valuation
Trailing PE 8.54 | Forward PE 5.82 | Enterprise Value 633889600 | Price to Sales(TTM) 2.6 |
Enterprise Value 633889600 | Price to Sales(TTM) 2.6 | ||
Enterprise Value to Revenue 14.93 | Enterprise Value to EBITDA 9.23 | Shares Outstanding 40137400 | Shares Floating - |
Shares Outstanding 40137400 | Shares Floating - | ||
Percent Insiders 1.46 | Percent Institutions 14.07 |
Analyst Ratings
Rating 3 | Target Price 7.92 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 8 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Triplepoint Venture Growth BDC Corp

Company Overview
History and Background
TriplePoint Venture Growth BDC Corp. (TPVG) was founded in 2014. It provides venture growth stage companies with debt financing, targeting companies backed by venture capital firms. It has grown organically, focusing on the technology, life sciences, and other high-growth sectors.
Core Business Areas
- Venture Growth Lending: Provides debt financing, primarily in the form of term loans, to venture growth stage companies.
- Equity Investments: Makes select equity investments, typically warrants received in connection with its debt investments.
Leadership and Structure
The company is led by Jim Labe (CEO) and is structured as a business development company (BDC), operating under a board of directors.
Top Products and Market Share
Key Offerings
- Term Loans: Provides term loans to venture-backed companies, typically ranging from $5 million to $40 million. Market share data is difficult to ascertain precisely due to the fragmented nature of venture debt. Competitors include Hercules Capital (HTGC), Ares Capital (ARCC), and Golub Capital BDC (GBDC).
- Warrants/Equity: Receives warrants or makes small equity investments in conjunction with debt financing. Revenue from these is variable. Competitors are other BDCs which also take similar warrants.
Market Dynamics
Industry Overview
The BDC industry provides capital to small and mid-sized businesses, often those unable to access traditional bank loans. The venture debt segment focuses specifically on funding high-growth companies backed by venture capital. Increased interest rates are impacting the cost of capital for borrowers.
Positioning
TPVG specializes in venture growth stage companies, targeting established businesses with demonstrated revenue and strong venture capital backing. Its competitive advantage lies in its expertise in assessing the creditworthiness of venture-backed firms.
Total Addressable Market (TAM)
The TAM for venture debt is estimated to be in the billions of dollars annually. TPVG is well-positioned to capture a portion of this market, focusing on established venture-backed companies. The exact TAM fluctuates based on overall venture capital investment activity.
Upturn SWOT Analysis
Strengths
- Experienced management team with expertise in venture lending
- Strong relationships with venture capital firms
- Focus on high-growth sectors like technology and life sciences
- Attractive dividend yield for investors
Weaknesses
- Higher risk profile due to lending to venture-backed companies
- Sensitivity to economic downturns and venture capital market conditions
- Reliance on a specific niche market
- Potential for non-accruals and credit losses
Opportunities
- Expansion into new sectors and geographies
- Increased demand for venture debt as companies stay private longer
- Potential for strategic acquisitions or partnerships
- Growing ecosystem of venture-backed companies
Threats
- Increased competition from other BDCs and alternative lenders
- Economic downturns impacting portfolio companies
- Changes in interest rates affecting profitability
- Regulatory changes impacting the BDC industry
Competitors and Market Share
Key Competitors
- HTGC
- ARCC
- GBDC
- MAIN
Competitive Landscape
TPVG competes with other BDCs and alternative lenders for venture debt deals. It differentiates itself through its expertise in venture lending and relationships with VC firms. The other BDCs listed can provide larger loan sizes.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: TPVG's growth has been tied to the venture capital market and its ability to deploy capital effectively. Past yearsu2019 performance can be pulled from SEC data.
Future Projections: Analyst estimates for future growth are variable, depending on market conditions.
Recent Initiatives: Recent initiatives are described in quarterly earnings call transcripts and investor presentations. Check their website for recent news
Summary
TriplePoint Venture Growth BDC Corp is a player in the venture debt market, specializing in lending to venture-backed companies. Its strengths include an experienced management team and focus on high-growth sectors. It faces risks associated with lending to venture-backed companies and competition from other lenders. Overall the company has high dividend yield and is positioned to grow if the venture market rebounds but must be weary of companies that may not be able to pay back their loans.
Similar Companies
- HTGC
- ARCC
- GBDC
- MAIN
Sources and Disclaimers
Data Sources:
- SEC Filings (10-K, 10-Q), Company Website, Investor Presentations, Financial News Outlets, Analyst Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and may not be precise. Financial performance and projections are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Triplepoint Venture Growth BDC Corp
Exchange NYSE | Headquaters Menlo Park, CA, United States | ||
IPO Launch date 2014-03-06 | Co-Founder, Chairman & CEO Mr. James Peter Labe | ||
Sector Financial Services | Industry Asset Management | Full time employees - | Website https://www.tpvg.com |
Full time employees - | Website https://www.tpvg.com |
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.